Erik Clary, DVM, Ph.D., DACVS, is an associate professor of small animal surgery and bioethics in the Department of Veterinary Clinical Sciences at OSU’s College of Veterinary Medicine. In addition to teaching veterinary students and performing surgery on clinical patients, Clary is an avid researcher.
“I am involved in the Institute for Translational and Emerging Research in Advanced Comparative Therapy or INTERACT in a couple of ways,” Clary said. “First, I serve on the internal advisory committee, working with Dr. Ranjan and others to get this exciting initiative through its early development. Second, I serve as a researcher utilizing the resources within INTERACT.
“As I think about it, at the core of INTERACT is a collaborative ethos propelling innovative research with the aim of advancing human and animal health. Indeed, one of the things within INTERACT that really excites me is the opportunity to collaborate with researchers here on OSU’s campus and beyond. Within the OSU community, I have active collaborations with colleagues in the engineering and agriculture colleges, and also with researchers in other departments of our veterinary college. Reaching beyond OSU, I am presently working with medical researchers at OUHSC, UCO, and the University of California, San Diego. I greatly value in my research the opportunity to collaborate with colleagues who bring different ideas and skills to the table—including researchers early in their career and people on the development side who can help translate research to the clinic setting. INTERACT offers a great vehicle for making that happen.”
Much of the research at the College of Veterinary Medicine focuses on the One Health concept of advancing in tandem the health of both animals and people.
“My goal is to be involved in research that brings forward innovations that can advance both human and animal health,” Clary said. “As one example, my OSU-CVM colleague, Dr. Valerie McElliott, and I are working with medical researchers at UC San Diego School of Medicine to establish the gene profile of certain kinds of tumors that we encounter in dogs that have a parallel tumor type in people. If we can understand a tumor’s genetic pattern, that can be a great assist in the effort to develop more targeted treatment strategies that offer greater chances for success with fewer side-effects.
“INTERACT is an exciting initiative. It’s bold, and I think it is off to a great start. On the near horizon, I aim to continue doing my part to facilitate its early development while leveraging in my own research activity its resources for teaming up with colleagues who are equally keen to initiate and develop impactful research.”
The Institute for Translational and Emerging Research in Advanced Comparative Therapy (INTERACT) aims to fulfill One Health research by conducting parallel investigations in both humans and animals. INTERACT promotes interdisciplinary research within the veterinary college, across the OSU campus and throughout the state and nation by developing and translating discoveries into therapies for patients. INTERACT has faculty participants from almost all OSU colleges, industry experts, foundation partners, and personnel from other academic institutions around the country. For more information, visit INTERACT or contact email@example.com.